A 62-year-old woman from Mumbai presents with a 2-week history of jaundice, right upper quadrant pain, and fever (38.5°C). She has a history of recurrent cholangitis. On examination, she is icteric and has right upper quadrant tenderness. Laboratory tests show total bilirubin 9.5 mg/dL (direct 8.1 mg/dL), ALP 410 U/L, ALT 320 U/L, WBC 14,200/μL, and INR 1.4. Abdominal ultrasound shows dilated intrahepatic bile ducts with multiple stones in the common bile duct and a dilated gallbladder. What is the most appropriate immediate management?

Explanation

## Clinical Scenario Analysis This patient presents with **acute cholangitis** (fever, jaundice, right upper quadrant pain — **Charcot's triad**) secondary to **choledocholithiasis** (CBD stones on ultrasound). She is **hemodynamically stable** (BP not stated as low, HR/temp controlled) but shows signs of **systemic inflammation** (fever, elevated WBC, coagulopathy). ## Management Algorithm for Acute Cholangitis ```mermaid flowchart TD A[Acute cholangitis + CBD stones]:::outcome A --> B{Hemodynamic status?}:::decision B -->|Unstable/septic shock| C[Immediate resuscitation + urgent ERCP/PTC]:::urgent B -->|Stable/mild sepsis| D[IV antibiotics + fluids]:::action D --> E{Timing of ERCP?}:::decision E -->|Mild disease| F[ERCP within 24-48 hrs]:::action E -->|Severe/worsening| G[ERCP within 12 hrs]:::action F --> H[Sphincterotomy + stone extraction]:::action G --> H C --> I[Percutaneous drainage if ERCP fails]:::action ``` ## Why IV Antibiotics + Fluid Resuscitation First **Key Point:** In **stable acute cholangitis**, the management sequence is: **resuscitation → antibiotics → ERCP within 24–48 hours**. Do NOT rush to ERCP in a stable patient without optimizing hemodynamics and starting antibiotics. **High-Yield:** The **2020 Tokyo Guidelines** recommend: 1. **Immediate:** IV fluids, broad-spectrum antibiotics (cover gram-negatives, anaerobes; e.g., ceftriaxone + metronidazole or piperacillin-tazobactam) 2. **Within 24–48 hours:** ERCP with sphincterotomy and stone extraction (for stable patients) 3. **Within 12 hours:** ERCP (for severe cholangitis or septic shock) **Clinical Pearl:** Correcting coagulopathy (INR 1.4) with **vitamin K** or **fresh frozen plasma** before ERCP reduces bleeding risk, especially if sphincterotomy is planned. ## Rationale Against Other Options | Option | Why Not? | |---|---| | **Immediate ERCP** | Patient is stable; rushing to ERCP without optimization increases risk of perforation and pancreatitis. Antibiotics and resuscitation must precede ERCP. | | **PTC with external drainage** | Reserved for cases where ERCP has **failed** or is **contraindicated** (e.g., altered anatomy, duodenal obstruction). First-line is ERCP. | | **Laparoscopic cholecystectomy** | **Contraindicated** in acute cholangitis with CBD stones. Surgery is deferred until cholangitis is resolved and stones are cleared. | **Mnemonic:** **"ABCD of Acute Cholangitis"** - **A**ntibiotics (broad-spectrum, IV) - **B**iliary drainage (ERCP within 24–48 hrs if stable) - **C**orrect coagulopathy (vitamin K, FFP) - **D**rain gallbladder (cholecystectomy deferred until acute phase resolves) ## Timing of ERCP **Tip:** The **urgency of ERCP depends on severity**: - **Mild cholangitis** (fever <38.5°C, stable vitals, normal mental status): ERCP within 24–48 hours - **Moderate/severe cholangitis** (fever >38.5°C, hypotension, altered mental status): ERCP within 12 hours - **Septic shock**: Immediate resuscitation + ERCP within 6–12 hours (or PTC if ERCP unavailable) This patient has **mild-to-moderate cholangitis** (fever 38.5°C, stable vitals), so ERCP within 24–48 hours is appropriate.